Frederick Lewis Altice MD, MA
Professor of Medicine (Infectious Diseases) and of Epidemiology (Microbial Diseases); Director, Clinical and Community Research; Director, HIV in Prisons Program; Director, Community Health Care Van; Icon Professor of Medicine, University of Malaya-Centre of Excellence for Research in AIDS (CERiA); Professor of Epidemiology and Public Health, Division of Epidemiology of Microbial Diseases
Departments & Organizations

Yale Medical Group
Office of International Medical Student Education
Global Health Initiative: Infectious Diseases
School of Public Health: Center for Interdisciplinary Research on AIDS
Internal Medicine: Viral Hepatitis Program | Infectious Diseases: AIDS Care Program
Research Interests
Interface between infectious diseases and substance abuse; HIV, HCV, and tuberculosis treatment in vulnerable populations (including injection drug users and prison inmates); antiretroviral therapy; extended release naltrexone, buprenorphine and methadone treatment in management of co-morbid conditions; healthcare integration; adherence interventions; behavioral interventions more...
Education
- M.D., Emory University, 1986
Selected Publications
- Zelenev, A., Marcus, R., Cruzado-Quinones, J., Spaulding, A., Desabrais, M., Lincoln, T., Altice, F.L., 2012. Patterns of Homelessness and Implications for HIV Health after Release from Jail AIDS Behav, In Press.
- Thompson, M.A., Mugavero, M.J., Amico, K.R., Cargill, V.A., Chang, L.W., Gross, R., Orrell, C., Altice, F.L., Bangsberg, D.R., Bartlett, J.G., Beckwith, C.G., Dowshen, N., Gordon, C.M., Horn, T., Kumar, P., Scott, J.D., Stirratt, M.J., Remien, R.H., Simoni, J.M., Nachega, J.B., 2012. Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel. Ann Intern Med, In Press.
- Springer, S.A., Qiu, J., Saber-Tehrani, A.S., Altice, F.L., 2012. Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners. PLoS One 7, e38335.


